retina

6 OCT pitfalls to avoidOptometry has widely adopted optical coherence tomography (OCT) as a mainstay in diagnosing and managing ocular disease since its advent in the 1990s
Details matter when prescribing meso-zeaxanthinRecently, there has been interest by pediatric ophthalmology in protecting our most valuable retinal real estate, the fovea, with dietary zeaxanthin
Long-term aflibercept effective for nAMD after other anti-VEGF therapies failedAflibercept (Eylea, Regeneron Pharmaceuticals) intravitreal injection, administered according to an as-needed regimen, improved the anatomic outcomes in many eyes refractory to monthly bevacizumab or ranibizumab injections that had persistent or recurrent fluid. However, half of the patients might require aflibercept injections every 4 weeks in order to achieve a completely dry retina.
Adalimumab effective but not a cure for uveitisAdalimumab (Humira, AbbVie), an immunosuppressive biologic therapy, improves the symptoms of noninfectious active uveitis, but causes some adverse events and does not cure the disease, researchers say.
Retinal prosthesis offers hope to blind patientsAn artificial retinal prosthesis allows patient with retinitis pigmentosa (RP) to locate objects, detect movement, and improve orientation and mobility skills.
Roth spots show as initial presentation in multiple myelomaRoth spots are hemorrhages in the retina with white centers. They occur in a wide variety of systemic conditions that are associated with retinal hemorrhages.
Importance of adherence and follow-up in patients with diabetic retinopathyA 37-year-old male came to my office for the first time in 2014 for a diabetes eye examination at the insistence of his primary-care provider (PCP).
NASEM declares eye health a public health imperativeIn order to avoid a public health crisis and keep up with increasing vision loss among the aging baby-boomer generation, correctable vision impairments must be eliminated by 2030, according to a report issued by the National Academies of Sciences, Engineering, and Medicine (NASEM).
The case of the disappearing drusen
The case of the disappearing drusenAt her periodic eye examination, a female patient in her early 70s was discovered to have low-risk macular degeneration in each eye. Further evaluation revealed that her visual acuity (VA) was correctable to 20/25 in each eye.
Study tracks clinical use of dexamethasone implant for DMEA 6-month analysis from the REINFORCE study of the dexamethasone intravitreal implant Ozurdex found an average of one- to two-line vision gains and no new safety concerns.